PMID: 2117102Jan 1, 1990Paper

Immunotherapy in allergic respiratory diseases

Lung
D VervloetJ Birnbaum

Abstract

Much more work is needed to specify the correct indications for immunotherapy in respiratory allergic diseases. Immunotherapy with pollen and mite extracts has shown some clinical efficacy versus placebo in controlled studies in allergic rhinitis and/or asthma. However, controlled studies comparing the cost, the risk factors and the efficacy of immunotherapy versus treatment with antihistaminic drugs, bronchodilators and topical steroids are needed. Additional studies are needed to established the place of immunotherapy in animal danders and mould allergy. In any case, before initiating immunotherapy in respiratory allergy the following questions must be answered: is there sufficient evidence of a close relationship between symptoms and allergen exposure? is it possible to achieve efficient allergen avoidance? is simple drug treatment no sufficient? is there evidence in the literature of effectiveness of IT for this allergen? is the patient able to comply with a long and constraining treatment?

References

Jun 1, 1977·The Journal of Allergy and Clinical Immunology·C A BruceL M Lichtenstein
Jan 1, 1978·British Journal of Diseases of the Chest·D A NewtonR Wilson
Jul 1, 1976·The Journal of Allergy and Clinical Immunology·H L PenceH A Selfridge
Sep 4, 1976·British Medical Journal·J GaddieK N Palmer
Dec 1, 1988·The Journal of Allergy and Clinical Immunology·T E Van MetreG L Rosenberg
Feb 1, 1989·The Journal of Allergy and Clinical Immunology
Jan 1, 1989·The Journal of Allergy and Clinical Immunology·J A FlingM J Reid
Aug 1, 1987·The Journal of Allergy and Clinical Immunology·E TaudorfB Weeke
Nov 27, 1987·JAMA : the Journal of the American Medical Association·P S Creticos, P S Norman
Apr 1, 1987·The Journal of Allergy and Clinical Immunology·R F LockeyS C Bukantz
May 1, 1987·The Journal of Allergy and Clinical Immunology·T A Platts-MillsS R Wilkins
Oct 1, 1986·The Journal of Allergy and Clinical Immunology·M J ReidB L Nelson
Nov 1, 1971·Annals of Internal Medicine·L M LichtensteinW L Winkenwerder
Jun 1, 1973·Clinical Allergy·E S Assem, M K McAllen
Apr 1, 1968·The American Journal of Medicine·L M LichtensteinW L Winkenwerder
Mar 20, 1969·The New England Journal of Medicine·N SadanL M Lichtenstein
Sep 23, 1965·The New England Journal of Medicine·F C Lowell, W Franklin
Mar 21, 1966·JAMA : the Journal of the American Medical Association·V J FontanaD Mainland
Sep 1, 1984·The Journal of Allergy and Clinical Immunology·J L OhmanK M Leitermann
Jan 30, 1982·British Medical Journal·D J HillM W Turner

❮ Previous
Next ❯

Citations

Jan 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·X Baur
Apr 22, 2008·The Cochrane Database of Systematic Reviews·P C Gøtzsche, H K Johansen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.